Progress in targeted signaling inhibition and immunotherapy has spurred a race to transform treatment across virtually all cancer disease sites. There is ample preclinical data pointing toward the ...

Researchers at Intermountain Health have been awarded a $356,000 grant from Merck, a global science and technology company ...

Severe flu infections can lead to a range of deadly complications, especially in people whose immune systems are compromised ...

Tea with honey—does it really help fight a cold? For years, this beverage has been considered a remedy for all upper ...